Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich
By Mayo Clinic staff
Born in Stimmersdorf, Czech Republic, in 1943, Kurt Glover-Ettrich was just an infant when his father was forced by the Nazi Party to fight for the German army on the Eastern Front during World War II. While his father reluctantly fought for the Germans, Kurt and his mother were uprooted from their home and forcibly taken to the largest and arguably the most infamous of all Nazi death camps: Auschwitz.
After a year inside Auschwitz, Kurt and his mother were in the process of being moved to a second concentration camp — Dauchau — in southwestern Germany when opportunity struck after the train transporting them and other prisoners went off the tracks and crashed. They not only survived the crash but used it as a chance to escape their captors. As Kurt tells the Mayo Clinic News Network, “We kept going and kept going until we couldn’t hear any more dogs barking, screaming, shooting.”
Kurt and his mother would spend the next four months on the run doing whatever was necessary to avoid being re-captured by the Nazis. Kurt’s father was taken prisoner by the Soviet army. When the war ended, Kurt and his mother hoped they’d finally be reunited with him. “Trains would come from Russia and bring home POWs,” Kurt says.
And so, from 1945 to 1949, Kurt and his mother religiously went to meet the “train bringing soldiers home” twice a year hoping to find his father. During the Jewish holiday of Hanukkah in 1949, they got their wish. “We heard a faint voice, ‘Ester, bist du das? (Ester is that you?)’” Kurt tells Mayo Clinic News Network. “We turned around, it was my father.”
Together again, Kurt’s parents would later decide to immigrate to the United States. Years later, after he turned 18, Kurt became an American citizen. “Tears came down my cheek,” he says. “I was so happy.”
Kurt chose to express the gratitude he felt for his new home and new life by enlisting to serve in the U.S. Army. “I wanted to give back,” he says. “It was the only way I could thank this great country called the United States of America and the American people for having allowed me to come here.”
After a 30-year military career that involved direct combat and facing hostile enemies as a Green Beret in the U.S. Army Special Forces, Kurt found himself facing a different kind of enemy: prostate cancer. His diagnosis led him to Mayo Clinic, where for the past 22 years, he’s received care led by advanced prostate cancer specialist Eugene Kwon, M.D. “He’s spent as much time with me as possible, explaining things,” Kurt says of Dr. Kwon. “And I know with him, I’m always in the best of hands.”
The same can be said for the laboratory medicine staff who have been integral members of Kurt’s care team at Mayo Clinic. “I appreciate that Dr. Kwon has scheduled me for regular lab testing through my treatment," Kurt says. “It provides Dr. Kwon with continued up-to-date information so that he can make the appropriate decisions as far as treatment is concerned."
Aggressive, individualized care
Dr. Kwon says Kurt’s treatment plan has mirrored that of other prostate cancer patients at Mayo Clinic. “We have a very aggressive plan for how we follow patients like Kurt,” Dr. Kwon says. “We use lab testing to track prostate-specific antigen, which is PSA, a blood marker, for prostate cancer every three months. In addition, we will also occasionally check to see how other organs in the body are functioning, such as bone metabolism, or markers in the liver, because these are areas that prostate cancer can spread to. And by monitoring those sites, you can sometimes figure out whether the cancer is starting to become active at sites outside of the prostate.”
Even though prostate cancer is often slow-growing, Dr. Kwon says regular lab testing is critical to staying on top of any changes in a patient’s health and disease state.
“I think one of the things we do very well here at Mayo is that we're very aggressive, if not obsessive, about keeping track of these markers for our patients through testing," he says. "Our general plan with all prostate cancer patients, including Kurt, is to check these markers every three months. I think just having someone watching and monitoring the situation gives patients great comfort that they’re not going to fall through the cracks.”
Comfort is exactly what Kurt says he’s felt throughout his time as a Mayo Clinic patient. “They walk me through everything and make sure I understand exactly what’s being done and what I need to do to keep living my life.”
For Kurt, continuing to live his life not only means staying alive but also moving to Rochester, Minnesota, so that he can spend four hours a day volunteering for Mayo Clinic. “This was the perfect opportunity,” Kurt says of becoming a Mayo Clinic volunteer. “I knew there were patients coming through here, military people coming through here that I can relate to. Not only talk to these people, but uplift their spirits, and instill in them that there is hope, that they’re in the right place.”
Watch this video to hear Kurt share his story:
Learn more
Learn more about prostate cancer and find a prostate cancer clinical trial at Mayo Clinic.
Join the Prostate Cancer Support Group on Mayo Clinic Connect, an online networking community for patients and families.
Also, read these articles:
- "Prostate cancer screening: Should you get a PSA test?"
- "Prostate cancer: Family history, genetics and your risk"
- "Importance of exercise for men with prostate cancer"
- "Signs there is a problem with your prostate"
A version of this story was originally published on the Mayo Clinic Laboratories website and on the Mayo Clinic News Network.
Related Posts
Read excerpts from the book "Mayo Clinic on Prostate Health" to learn about hormone therapy for advanced prostate cancer and relieving advanced prostate cancer pain.
Dr. Oliver Sartor discusses treatment for prostate cancer that has spread to other parts of the body and the use of PSA tests to reduce risk.
Learn about the roles played by family history and genetics in the development and treatment of prostate cancer.